Cyteir Therapeutics
Why Robinhood?
You can watch CYTT and buy or sell other stocks, ETFs, and their options commission-free!About CYTT
Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies.
CYTT Key Statistics
Stock Snapshot
Cyteir Therapeutics(CYTT) stock is priced at $3.01, giving the company a market capitalization of 108.35M. It carries a P/E multiple of -3.23.
On 2026-04-05, Cyteir Therapeutics(CYTT) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Cyteir Therapeutics(CYTT) stock has reached 0, versus its average volume of 645.29K.
The stock's 52-week range extends from a low of $1.65 to a high of $3.19.
The stock's 52-week range extends from a low of $1.65 to a high of $3.19.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.